Keywords: NASH، استاتو هپاتیت غیر الکل; T2DM, type 2 diabetes mellitus; CVD, cardiovascular disease; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; HSCs, hepatic stellate cells; ER, endoplasmic reticulum; UPR, unfolded protein response; MCD, methionine- and choline
مقالات ISI NASH، استاتو هپاتیت غیر الکل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NASH، استاتو هپاتیت غیر الکل; DW, diffusion-weighted; MR, magnetic resonance; ADC, apparent diffusion coefficient; CT, computed tomography; NASH, nonalcoholic steatohepatitis; HCC, hepatocellular carcinoma; ROI, region of interestHemangioma; Cirrhosis; Chronic liver disease; Diffusion
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD, nonalcoholic fatty liver disease; NAFL, nonalcoholic fatty liver; NASH, nonalcoholic steatohepatitis; T2DM, type 2 diabetes mellitus; MetS, metabolic syndrome; CVD, cardiovascular disease; LDL-C, low-density lipoprotein cholesterol; ULN, upper limi
Keywords: NASH، استاتو هپاتیت غیر الکل; HSCs, hepatic stellate cells; TQ, thymoquinone; NASH, nonalcoholic steatohepatitis; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; CBDL, common bile duct ligation; LPS, lipopolysaccharide; CCl4, carbon tetrachl
Keywords: NASH، استاتو هپاتیت غیر الکل; ALT, alanine aminotransferase; ER, endoplasmic reticulum; FFA, free fatty acid; HFD, high-fat diet; HSP70, heat shock protein 70; mtHSP70, mitochondrial heat shock protein 70; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PA
Keywords: NASH، استاتو هپاتیت غیر الکل; NASH; Histology; Diagnosis; PrognosisAH, alcoholic hepatitis; ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; IL, interleukin; K, keratin; MIR, microRNA; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Keywords: NASH، استاتو هپاتیت غیر الکل; Microbiota; Endotoxin; Alcoholic SteatohepatitisFXR, farnesoid X receptor; IL, interleukin; LPS, lipopolysaccharide; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PAMP, pathogen-associated molecular pattern; PCR, polymerase
Keywords: NASH، استاتو هپاتیت غیر الکل; ED, erectile dysfunction; MetS, metabolic syndrome; NASH, nonalcoholic steatohepatitis; CVD, cardiovascular disease; T, testosterone; FXR, farnesoid X receptor; OCA, obeticholic acid; RD, regular diet; Ach, acetylcholine; T2DM, type 2 diabetes mellitus; N
Keywords: NASH، استاتو هپاتیت غیر الکل; Nonalcoholic Fatty Liver Disease; Lipotoxicity; Wound-Healing Response; MisrepairNAFL, nonalcoholic fatty liver; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; SHH, sonic hedgehog; SMO, smoothened, frizzled class receptor; TN
Keywords: NASH، استاتو هپاتیت غیر الکل; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; HR, hazard ratio; NASH, nonalcoholic steatohepatitis; sVEGFR1, soluble vascular endothelial growth factor receptor 1; sVEGFR2, soluble vascular endothelial growth factor recept
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD, non-alcoholic fatty liver disease; MSCS, mainstream cigarette smoke; NASH, nonalcoholic steatohepatitis; MCDHF, methionine- and choline-deficient plus high fat; CSE, cigarette smoke extract; KCs, Kupffer cells; SSCS, side stream CS; NAS, NAFLD acti
MicroRNA changes, activation of progenitor cells and severity of liver injury in mice induced by choline and folate deficiency
Keywords: NASH، استاتو هپاتیت غیر الکل; Liver injury; Methyl-donor deficient diet; Mouse; MicroRNA; Progenitor cellsNAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; miRNA, microRNA; mRNA, messenger RNA; CFD, choline- and folate-deficient; cDNA, complementary DNA; IPA
Chemical characteristics for optimizing CYP2E1 inhibition
Keywords: NASH، استاتو هپاتیت غیر الکل; Cytochrome P450 2E1; Topliss; Alcoholic liver disease; Nonalcoholic liver diseaseASH, alcoholic steatohepatitis; NASH, nonalcoholic steatohepatitis; CYP2E1, cytochrome P450 2E1; NADP+, nicotinamide adenine dinucleotide phosphate; TCA, tri-chloro-acetic ac
Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats
Keywords: NASH، استاتو هپاتیت غیر الکل; CO2, Carbon Dioxide; CYP 7A1, Cholesterol 7 alpha-hydroxylase; CD68, Cluster of Differentiation 68; cDNA, Complementary DNA; D, Day; FLX, Fluoxetine; L, Light; MCP1, Monocyte Chemotactic Protein; NASH, Nonalcoholic Steatohepatitis; PND, Postnatal Day; SSR
Hepatitis B virus infection in patients with metabolic syndrome: A complicated relationship. Results of a population based study
Keywords: NASH، استاتو هپاتیت غیر الکل; HDL, high density lipoproteins; LDL, low density lipoproteins; TG, triglycerides; MS, metabolic syndrome; HBI, hepatitis B infection; HBV, hepatitis B virus; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; AST, aspartate amino
MRI evaluation of fatty liver in day to day practice: Quantitative and qualitative methods
Keywords: NASH، استاتو هپاتیت غیر الکل; BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PDFF, proton density fat fraction; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; GRE, gradient echo; TE, echo time; TR, repetition
Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD; sleep disorders; insomnia; sleep apnea; restless leg syndromeNAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; DM, diabetes mellitus; OSA, obstructive sleep apnea; BMI, body mass index; CLD, chronic liver disease; ALD, al
Elastography and Contrast-enhanced Ultrasonography in the Early Detection of Hepatocellular Carcinoma in an Experimental Model of Nonalcoholic Steatohepatitis
Keywords: NASH، استاتو هپاتیت غیر الکل; hepatocellular carcinoma; liver stiffness; nonalcoholic steatohepatitis; ultrasonographyHCC, hepatocellular carcinoma; NASH, nonalcoholic steatohepatitis; US, ultrasound; CEUS, contrast-enhanced ultrasonography
Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and Intralipid solutions and correlation to insulin levels
Keywords: NASH، استاتو هپاتیت غیر الکل; FF, Fat fraction; GLU + IL, Glucose + Intralipid; IP, In-phase; MR, Magnetic resonance; MRI, Magnetic resonance imaging; MRS, Magnetic resonance spectroscopy; NAFLD, Nonalcoholic fatty liver disease; NASH, Nonalcoholic steatohepatitis; OP, Opposed-phase;
The Future Liver of the Asia Pacific: Fatter and Firmer from More Fructose and Fortune?
Keywords: NASH، استاتو هپاتیت غیر الکل; nonalcoholic steatohepatitis; fatty liver; Asia Pacific; reviewNAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; BMI, body mass index; HCC, hepatocellular carcinoma; CURES, Chennai Urban Rural Epidemiology Study; HBV, hepatitis
Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation
Keywords: NASH، استاتو هپاتیت غیر الکل; ARE, Antioxidant response element; Nrf2, Nuclear factor erythroid 2-like 2; KO, Knockout; WT, Wild-type; P450, Cytochrome P450; NASH, Nonalcoholic steatohepatitis; NAFLD, Nonalcoholic fatty liver disease; co-IP, Co-immunoprecipitationCoumarin 7-hydroxylas
Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; HSCs, hepatic stellate cells; EMT, epithelial to mesenchymal transition; ECM, extracellular matrix; LPS, lipopolysaccharide; TLRs, Toll-like receptors; TIR, Toll/IL-1 receptor; P
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; BA, bile acid; CA, cholic acid; DCA, deoxycholic acid; CDCA, chenodeoxycholic acid; TCA, taurocholic acid; TDCA, taurodeoxycholic acid; GCA, glycocholic acid; GDCA, glycodeoxycho
Liver carcinogenesis: Rodent models of hepatocarcinoma and cholangiocarcinoma
Keywords: NASH، استاتو هپاتیت غیر الکل; CCA, cholangiocarcinoma; CCl4, carbon tetrachloride; CDD, choline deficient diet; DEN, N-nitrosodiethylamine; HCC, hepatocellular carcinoma; NAFLD, non-alcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PB, phenobarbital; PH, partial hepat
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
Keywords: NASH، استاتو هپاتیت غیر الکل; AHA, American Heart Association; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BIB, Bioenterics intragastric balloon; BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Dietary protein restriction induces steatohepatitis and alters leptin/signal transducers and activators of transcription 3 signaling in lactating rats
Keywords: NASH، استاتو هپاتیت غیر الکل; PR, protein restriction; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; AMPK, 5′-adenosine monophosphate-activated protein kinase; VLDL, very-low-density lipoprotein; HSCs, hepatic stellate cells; NADPH, nicotinamide adenine
Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function
Keywords: NASH، استاتو هپاتیت غیر الکل; NASH, nonalcoholic steatohepatitis; HFD, high-fat diet; LA, α-lipoic acid; ATP, adenosine triphosphate; AMPK, adenosine monophosphate-activated protein kinase; ETC, electron transport chain; OXPHOS, oxidative phosphorylationMitochondrial dysfunction; High
Liver Transplantation for Hepatocellular Carcinoma: Long-Term Results Suggest Excellent Outcomes
Keywords: NASH، استاتو هپاتیت غیر الکل; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; MELD, Model for End-Stage Liver Disease; NASH, nonalcoholic steatohepatitis; RFA, radiofrequency ablation; TACE, transarterial chemoembolization
Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: Long-term results
Keywords: NASH، استاتو هپاتیت غیر الکل; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; FFAs, free fatty acids; GGT, γ glutamyl-transferase; NAFLD, nonalcoholic fatty liver disease; NAS, NAFLD activity score; NASH, nonalcoholic steatohepatitis; UDCA, ursode
Potential mechanisms for the emerging link between obesity and increased intestinal permeability
Keywords: NASH، استاتو هپاتیت غیر الکل; L, lactulose; L/M, lactulose/mannitol ratio; LPS, lipopolysaccharide; L/S, lactulose/sucralose ratio; M, mannitol; NASH, nonalcoholic steatohepatitis; S, sucralose; SCFAs, short-chain fatty acids; SIBO, small intestinal bacterial overgrowth; TLRs, Toll-li
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
Keywords: NASH، استاتو هپاتیت غیر الکل; Liver Disease; Organ Transplantation; Complications of Obesity; SteatosisBMI, body mass index; CC, cryptogenic cirrhosis; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; SRTR, Scientific Registry of Transplant Recipients
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD; NASH: Prevalence; Ultrasound: Liver Biopsy; Fatty Liver Disease; Hepatic SteatosisALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Non-alcoholic fatty liver disease: epidemiology, pathophysiology, diagnosis and treatment
Keywords: NASH، استاتو هپاتیت غیر الکل; fatty liver; nonalcoholic fatty liver disease; NASH; obesityNAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; BMI, body mass index; FFA, free fatty acid; TG, triglyceride
Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis
Keywords: NASH، استاتو هپاتیت غیر الکل; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; NASH, nonalcoholic steatohepatitis; TNF-α, tumor necrosis factor-α
Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PAI-1, plasminogen activator inhibitor-1; sICAM-1, soluble intercellular adhesion molecule-1; sCD40L, soluble CD40 ligand; ELISA, enzyme-linked immuno-sorbent assayICAM-1; PAI-1;
HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Keywords: NASH، استاتو هپاتیت غیر الکل; Hepatic Fibrosis; hfe Gene; Iron Overload; Nonalcoholic Fatty Liver DiseaseBMI, body mass index; GGT, γ-glutamyltranspeptidase; HFE, hemochromatosis gene; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease
Keywords: NASH، استاتو هپاتیت غیر الکل; Fatty acids; Hepatic steatosis; Insulin resistance; Metabolic syndrome; Mitochondrial dysfunction; Visceral adiposityFFA, Free fatty acids; IRS-1, Insulin-receptor substrate-1; NAFLD, Nonalcoholic fatty liver disease; NASH, Nonalcoholic steatohepatitis; P
SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFDL, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; SREBP-1c, sterol regulatory binding protein-1c; LXR, liver X-activated receptors; HF-F, high-fat diet plus fructose; DHEA, dehydroepiandrosterone; TG, triglyceride; TC, total cho
Heritability of Nonalcoholic Fatty Liver Disease
Keywords: NASH، استاتو هپاتیت غیر الکل; BMI, body mass index; h2, narrow sense heritability; MRI, magnetic resonance imaging; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
Keywords: NASH، استاتو هپاتیت غیر الکل; ACR, American College of Rheumatology; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; NASH, nonalcoholic steatohepatitis; NSAID, nonsteroidal anti-inflamm
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Keywords: NASH، استاتو هپاتیت غیر الکل; BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia
Keywords: NASH، استاتو هپاتیت غیر الکل; Liver steatosis; Nonalcoholic steatohepatitis; Obesity; Diabetes mellitusNAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; MSG, monosodium glutamate; HCC, hepatocellular carcinoma; ADI, average daily intake; NAS, NAFLD activity
Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
Keywords: NASH، استاتو هپاتیت غیر الکل; ALT, alanine aminotransferase; GGT, γ-glutamyltransferase; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
Keywords: NASH، استاتو هپاتیت غیر الکل; EOT, end of treatment; HOMA, homeostasis model assessment; NAS, nonalcoholic fatty liver disease activity score; NASH, nonalcoholic steatohepatitis; QUICKI, quantitative insulin-sensitivity check index
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD, Nonalcoholic fatty liver disease; NASH, Nonalcoholic steatohepatitis; PCOS, polycystic ovary syndrome; BMI, body mass index; ALT, alanine aminotransferases; hsCRP, high-sensitive C-reactive protein; HOMA-IR, homeostasis model assessment of insulin
Association Between Nonalcoholic Hepatic Steatosis and Hepatic Cytochrome P-450 3A Activity
Keywords: NASH، استاتو هپاتیت غیر الکل; CYP3A, cytochrome P-450 3A; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PCR, polymerase chain reaction; PXR, pregnane xenobiotic receptor; SV, splice variant; wt, wild-type
Prevalence of Nonalcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Keywords: NASH، استاتو هپاتیت غیر الکل; BMI, body mass index; GGT, γ-glutamyltransferase; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; LDL, low-density lipoprotein; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PCOS,
Growth Hormone Reverses Nonalcoholic Steatohepatitis in a Patient With Adult Growth Hormone Deficiency
Keywords: NASH، استاتو هپاتیت غیر الکل; AGHD, adult growth hormone deficiency; GH, growth hormone; hsCRP, high sensitive C-reactive protein; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; 8OHdG, 8-hydroxydeoxyguanosine; rhGH, recombinant human GH; ROS, reactive oxy
Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice
Keywords: NASH، استاتو هپاتیت غیر الکل; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; MCD, methionine–choline deficient diet; SNAC, S-Nitroso-N-acetylcysteine; MTP, microsomal triglyceride transfer proteinNAFLD; NASH; MCD diet; MTP; S-Nitroso-N-acetylcysteine; SNA
Identification of a gene-pathway associated with non-alcoholic steatohepatitis
Keywords: NASH، استاتو هپاتیت غیر الکل; NASH, nonalcoholic steatohepatitis; SAMe, S-AdenosylmethionineGene-pathway; Non-alcoholic steatohepatitis; S-adenosylmethionine; Sp1